Elevance Health, Inc.

NYSE:ELV 주식 보고서

시가총액: US$92.9b

Elevance Health 미래 성장

Future 기준 확인 1/6

Elevance Health (는) 각각 연간 12.7% 및 6.8% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 15.8% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 17.6% 로 예상됩니다.

주요 정보

12.7%

수익 성장률

15.8%

EPS 성장률

Healthcare 수익 성장21.1%
매출 성장률6.8%
향후 자기자본 수익률17.6%
애널리스트 커버리지

Good

마지막 업데이트12 Nov 2024

최근 미래 성장 업데이트

Recent updates

We Think Elevance Health's (NYSE:ELV) Profit Is Only A Baseline For What They Can Achieve

Oct 29
We Think Elevance Health's (NYSE:ELV) Profit Is Only A Baseline For What They Can Achieve

Elevance Health: A Bad Q3 Was Almost Inevitable Given Industry Headwinds

Oct 17

Elevance: Our Top Value Pick Trading At 12.5x Earnings And Growing At 12.5%

Oct 10

Is Now An Opportune Moment To Examine Elevance Health, Inc. (NYSE:ELV)?

Oct 08
Is Now An Opportune Moment To Examine Elevance Health, Inc. (NYSE:ELV)?

Investors Continue Waiting On Sidelines For Elevance Health, Inc. (NYSE:ELV)

Sep 11
Investors Continue Waiting On Sidelines For Elevance Health, Inc. (NYSE:ELV)

Elevance Health: Strong Earnings Growth Supports Strong Dividend Growth

Sep 06

There's Been No Shortage Of Growth Recently For Elevance Health's (NYSE:ELV) Returns On Capital

Aug 29
There's Been No Shortage Of Growth Recently For Elevance Health's (NYSE:ELV) Returns On Capital

Here's Why We Think Elevance Health (NYSE:ELV) Is Well Worth Watching

Aug 02
Here's Why We Think Elevance Health (NYSE:ELV) Is Well Worth Watching

Elevance Health: Healthcare Services Segment Is Gaining Traction

Jul 31

Elevance Health: Buy A Dividend Growth Machine

Jul 18

Elevance Health: Favorable Trends Are Emerging (Rating Upgrade)

Jun 28

Is Now An Opportune Moment To Examine Elevance Health, Inc. (NYSE:ELV)?

Jun 11
Is Now An Opportune Moment To Examine Elevance Health, Inc. (NYSE:ELV)?

Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher

May 27
Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher

We Think Shareholders Will Probably Be Generous With Elevance Health, Inc.'s (NYSE:ELV) CEO Compensation

May 09
We Think Shareholders Will Probably Be Generous With Elevance Health, Inc.'s (NYSE:ELV) CEO Compensation

Elevance Health (NYSE:ELV) Has Announced A Dividend Of $1.63

Apr 25
Elevance Health (NYSE:ELV) Has Announced A Dividend Of $1.63

Elevance Health: It's Not Too Late To Buy Their Dividend Growth

Apr 23

Is Elevance Health (NYSE:ELV) Using Too Much Debt?

Apr 16
Is Elevance Health (NYSE:ELV) Using Too Much Debt?

Elevance Health: Not Doing Enough In 2024 To Justify Premium Price

Apr 11

Elevance Health, Inc.'s (NYSE:ELV) Earnings Haven't Escaped The Attention Of Investors

Apr 01
Elevance Health, Inc.'s (NYSE:ELV) Earnings Haven't Escaped The Attention Of Investors

Elevance: A Healthy Dose Of Dividend Growth

Mar 21

Elevance Heath: Financial Growth And Technical Strength Indicate A Buy

Mar 07

Elevance Health (NYSE:ELV) Will Pay A Larger Dividend Than Last Year At $1.63

Feb 19
Elevance Health (NYSE:ELV) Will Pay A Larger Dividend Than Last Year At $1.63

Elevance Health: Time To Buy This Incredible Dividend Growth Stock

Jan 26

Slowing Rates Of Return At Elevance Health (NYSE:ELV) Leave Little Room For Excitement

Jan 19
Slowing Rates Of Return At Elevance Health (NYSE:ELV) Leave Little Room For Excitement

Is Elevance Health (NYSE:ELV) A Risky Investment?

Jan 02
Is Elevance Health (NYSE:ELV) A Risky Investment?

Elevance Health, Inc.'s (NYSE:ELV) Shares Not Telling The Full Story

Dec 18
Elevance Health, Inc.'s (NYSE:ELV) Shares Not Telling The Full Story

A Look At Elevance's Margin Dynamics

Nov 23

Is It Time To Consider Buying Elevance Health, Inc. (NYSE:ELV)?

Nov 16
Is It Time To Consider Buying Elevance Health, Inc. (NYSE:ELV)?

Elevance Health: A High Conviction Defensive Blue Chip Buy

Oct 19

These 4 Measures Indicate That Elevance Health (NYSE:ELV) Is Using Debt Safely

Oct 04
These 4 Measures Indicate That Elevance Health (NYSE:ELV) Is Using Debt Safely

Elevance: Pave The Way For The Next UnitedHealth

Sep 21

Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital

Sep 18
Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital

Here's The Price I Would Buy Elevance Health Stock

Sep 13

If EPS Growth Is Important To You, Elevance Health (NYSE:ELV) Presents An Opportunity

Aug 18
If EPS Growth Is Important To You, Elevance Health (NYSE:ELV) Presents An Opportunity

Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?

Aug 04
Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?

Narrowing Down High-Quality Dividend Growth: Elevance Health Is Elemental

Jul 24

Elevance Health: Beaten Down Share Price Offers Solid Potential

Jul 10

Here's Why Elevance Health (NYSE:ELV) Can Manage Its Debt Responsibly

Jul 05
Here's Why Elevance Health (NYSE:ELV) Can Manage Its Debt Responsibly

Elevance Health: A Critical Update (Rating Downgrade)

Jun 05

Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher

Jun 04
Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher

Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?

May 05
Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?

We Think Elevance Health (NYSE:ELV) Can Stay On Top Of Its Debt

Apr 04
We Think Elevance Health (NYSE:ELV) Can Stay On Top Of Its Debt

수익 및 매출 성장 예측

NYSE:ELV - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
12/31/2026200,6428,7858,7929,16412
12/31/2025187,2897,5307,5798,04915
12/31/2024175,1116,3435,0325,44312
9/30/2024174,0156,4188712,131N/A
6/30/2024171,7196,6918202,067N/A
3/31/2024171,7456,2442,2963,570N/A
12/31/2023171,3405,9876,7658,061N/A
9/30/2023168,6265,9968,2469,514N/A
6/30/2023165,7166,31010,57111,825N/A
3/31/2023160,6766,09411,12812,327N/A
12/31/2022156,5995,8947,2478,399N/A
9/30/2022153,2516,16610,39511,589N/A
6/30/2022149,1346,0728,0229,169N/A
3/31/2022144,3536,2287,2638,400N/A
12/31/2021138,6436,1587,2778,364N/A
9/30/2021133,8835,5189,48010,505N/A
6/30/2021129,2194,2315,7786,851N/A
3/31/2021124,6324,7149,65710,678N/A
12/31/2020121,8684,5729,66710,688N/A
9/30/2020117,4494,9557,1088,202N/A
6/30/2020112,9655,9169,96011,019N/A
3/31/2020109,1674,7795,8996,946N/A
12/31/2019104,2124,8074,9846,061N/A
9/30/2019100,1654,2984,1515,197N/A
6/30/201996,7424,0743,0074,137N/A
3/31/201994,2203,9892,0183,242N/A
12/31/201892,0913,7502,6193,827N/A
9/30/201891,4094,5568912,063N/A
6/30/201890,5844,344N/A3,861N/A
3/31/201890,0614,145N/A3,712N/A
12/31/201790,0493,843N/A4,185N/A
9/30/201789,0552,980N/A5,763N/A
6/30/201788,0382,851N/A4,322N/A
3/31/201787,0832,777N/A4,599N/A
12/31/201684,8622,470N/A3,270N/A
9/30/201683,3642,282N/A3,943N/A
6/30/201681,8662,319N/A3,322N/A
3/31/201680,4122,398N/A3,825N/A
12/31/201579,1582,560N/A4,212N/A
9/30/201577,9592,886N/A3,472N/A
6/30/201576,6052,862N/A3,734N/A
3/31/201575,0662,734N/A3,632N/A
12/31/201473,8862,560N/A3,369N/A
9/30/201472,7922,362N/A3,337N/A
6/30/201472,0902,385N/A4,129N/A
3/31/201471,3072,453N/A3,483N/A
12/31/201371,0242,634N/A3,052N/A

애널리스트 미래 성장 예측

수입 대 저축률: ELV 의 연간 예상 수익 증가율( 12.7% )이 saving rate( 2.6% 보다 높습니다. ).

수익 vs 시장: ELV 의 연간 수익( 12.7% ) US 시장( 15.3% 보다 느리게 성장할 것으로 예상됩니다. 15.3% 연간).

고성장 수익: ELV 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.

수익 대 시장: ELV 의 수익(연간 6.8% ) US 시장( 8.9% 보다 느리게 성장할 것으로 예상됩니다. 8.9% 연간).

고성장 수익: ELV 의 수익(연간 6.8% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: ELV 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 17.6 %).

성장 기업 발견

7D

1Y

7D

1Y

7D

1Y